Rafael Closes Merger With Cyclo Therapeutics

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Rafael Closes Merger With Cyclo Therapeutics

, MT Newswires - 10:22 AM ET 3/26/2025 default

10:22 AM EDT, 03/26/2025 (MT Newswires) -- Rafael Holdings ( RFL ) and Cyclo Therapeutics ( CYTH ) said Wednesday they have completed their merger following shareholders' approval from both companies.

Rafael ( RFL ) issued Class B shares, representing 22% of the combined business, to the shareholders of Cyclo Therapeutics ( CYTH ), based on the exchange ratio determined at 0.3525, the companies said.

Rafael ( RFL ) also issued warrants to buy Rafael Class B shares to some holders of Cyclo Therapeutics ( CYTH ) warrants, they added.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.